- Arcus Biosciences (RCUS, Financial) will host a conference call on May 6, 2025, to discuss Q1 2025 financial results and pipeline updates.
- Interested participants can dial in or register online to join the call.
- The webcast and presentation will be available on the company's website, with a replay option afterwards.
Arcus Biosciences (RCUS), a global biopharmaceutical company known for developing innovative cancer therapies, has scheduled a conference call and webcast on May 6, 2025. The event, set to begin at 1:30 PM PT / 4:30 PM ET, will cover the company's financial performance and the latest updates on its drug development pipeline for the first quarter ending March 31, 2025.
Investors and interested parties can access the live conference by calling +1 (404) 975-4839 for local or +1 (833) 470-1428 toll-free, using Access Code 762544. Alternatively, participants can register online to listen to the call. The webcast and its accompanying slide presentation are accessible through the "Investors & Media" section on Arcus Biosciences' website at www.arcusbio.com. A replay of the webcast will be available after the live broadcast.
Arcus Biosciences, established in 2015, focuses on the development of unique molecules and combination therapies aimed at treating cancer. The company collaborates with industry partners, patients, and healthcare professionals globally to expedite the delivery of groundbreaking medicines targeting well-characterized biological pathways. Arcus is currently involved in clinical studies for several investigational medicines, including novel approaches involving TIGIT, PD-1, and other biological targets.
